Caption Management’s KALA BIO KALA Stock Holding History

Caption Management’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10	Closed	-$215K	–	1077
2020 Q1	$215K	Buy	+10	New	+$160K	0.01%	689

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's KALA Position: Q2 2020 in Review

Caption Management sold out of KALA BIO (KALA) in Q2 2020, closing a stake of 10 shares — an estimated $215K sold.

Caption Management first reported a position in KALA in Q1 2020 and held it in 1 quarter. The position peaked at $215K in Q1 2020. 113 funds tracked by Wall St. Rank hold KALA as of Q2 2020.

Caption Management reported no remaining KALA BIO position as of Q2 2020 after selling out during the quarter.
Caption Management sold 10 KALA BIO shares in Q2 2020, an estimated $215K.
Caption Management first reported a position in KALA BIO in Q1 2020 and held it in 1 quarter.
Caption Management's KALA BIO position peaked at $215K in Q1 2020.
113 funds tracked by Wall St. Rank held KALA BIO as of Q2 2020.

Based on Caption Management's 13F filing for Q2 2020, filed 14 Aug 2020.